Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selective targeting of histone deacetylase 11 disables metabolism of myeloproliferative neoplasms
    Meeting Abstract

    Sharma, V.; Yue, L.; Horvat, N. P.; Christodoulidou, A.; Akuffo, A. A.; Beatty, M.; Murdun, C.; Billington, J.; Goodheart, W. E.; Sahakian, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • PRMT5 inhibition modulates E2F1 methylation and gene regulatory networks leading to therapeutic efficacy in JAK2VF mutant MPN
    Meeting Abstract

    Pastore, F.; Bhagwat, N.; Krishnan, A.; Pastore, A.; Li, B.; Bowman, R. L.; Xiao, W.; Viny, A. D.; Karzai, A.; Zouak, A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Single cell DNA sequencing identifies combinatorial mutation patterns and clonal architecture in myeloid malignancies
    Meeting Abstract

    Miles, L. A.; Bowman, R. L.; Merlinsky, T. R.; Ooi, A.; Mendez, P.; Famulare, C.; Patel, M. A.; Bolton, K.; Palmisiano, N.; Carroll, M. P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Results from a first-in-human, proof-of-concept phase 1 trial in pretreated B-cell malignancies for loxo-305, a next-generation, highly selective, non-covalent BTK inhibitor
    Meeting Abstract

    Mato, A. R.; Flinn, I. W.; Pagel, J. M.; Brown, J. R.; Cheah, C. Y.; Coombs, C. C.; Patel, M. R.; Rothenberg, S. M.; Tsai, D. E.; Ku, N. C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • A phase Ia/Ib study exploring the synthetic lethality of the orally administered novel BTK inhibitor, Dtrmwxhs-12 (DTRM-12), in combination with everolimus and pomalidomide in patients with relapsed/refractory CLL, DLBCL or other B-cell lymphomas
    Meeting Abstract

    Mato, A. R.; Schuster, S. J.; Foss, F. M.; Isufi, I.; Ding, W.; Brander, D. M.; Sitlinger, A.; Tun, H. W.; Moustafa, M. A.; Kennard, K.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Efficacy of therapies following venetoclax discontinuation in CLL: Focus on B-cell receptor signal transduction inhibitors and cellular therapies
    Meeting Abstract

    Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Jacobs, R.; Hill, B. T.; Lamanna, N.; Brander, D. M.; Shadman, M.; Ujjani, C.; Yazdy, M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Combined treatment with lenalidomide and epoetin alfa leads to durable responses in patients with epo-refractory, lower risk non-deletion 5q [del(5q)] MDS: Final results of the E2905 intergroup phase III study - An ECOG-ACRIN Cancer Research Group study, Grant CA180820, and the National Cancer Institute of the National Institutes of Health
    Meeting Abstract

    List, A. F.; Sun, Z.; Verma, A.; Bennett, J. M.; McGraw, K.; Maciejewski, J. P.; Komrokji, R. S.; Wassenaar, T. R.; Luger, S. M.; Mattison, R. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Expansion of prior existing TP53 mutated clones in polycythemia vera patients treated with idasanutlin
    Meeting Abstract

    Marcellino, B.; Cassinat, B.; Farnoud, N.; Lu, M.; Verger, E.; McGovern, E.; Patel, M. A.; Kosiorek, H. E.; Mehrotra, M.; Houldsworth, J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Aberrant RNA splicing contributes to the pathogenesis of EVI-rearranged myeloid leukemias
    Meeting Abstract

    Inoue, D.; Lee, S. C.; Yoshimi, A.; Taylor, J.; Bitner, L. E.; Tanaka, A.; Hayashi, Y.; Cho, H. N.; Fukui, C.; Saganty, R.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Spliceosomal disruption of the non-canonical SWI/SNF chromatin remodeling complex in SF3B1 mutant leukemias
    Meeting Abstract

    Inoue, D.; Guo-Liang, C.; Liu, B.; Lee, S. C.; Michel, B. C.; Pangallo, J.; D'Avino, A. R.; North, K.; Bitner, L. E.; Xiao, M.; more...
    Blood (2019)

    Fulltext@MSK | Save